Rocket Lab Q2 2026 Earnings: Record $234M Revenue, a $2.36B Backlog and $1.9B of New Equity

Rocket Lab's second quarter of 2026 set records on every line the press release chose to highlight: revenue of $234.1 million, up 62% year over year, and a backlog of $2.36 billion, up 137%. It also closed two acquisitions — Mynaric, paid for entirely in stock, and Motiv, paid for in cash — and signed a deal to buy Iridium. The income statement improved: the net loss narrowed from $66.4 million to $49.3 million, and loss per share from $0.13 to $0.08. The balance sheet is where the quarter really happened. In the first six months of 2026, Rocket Lab's paid-in capital rose by $1.87 billion, goodwill and intangible assets rose by $189 million, and total assets nearly doubled to $4.19 billion. This is a company growing on equity, and the ledger shows exactly how much.

The Headline Numbers​

All figures are GAAP, in millions of US dollars, from the Q2 2026 Form 10-Q and the earnings release filed with it on August 10, 2026.

A common reading of the quarter is that the acquisitions pushed EPS negative. The filing does not support that framing: Rocket Lab's EPS was already negative — it has reported a net loss in every year this ledger covers — and in Q2 2026 it got less negative, from −$0.13 to −$0.08. What the acquisitions did is keep the improvement smaller than it would otherwise have been. The 10-Q attributes $13.2 million of revenue and a $13.2 million operating loss to Mynaric for the quarter, and $1.4 million of revenue and a $0.2 million operating loss to Motiv. The earnings release's non-GAAP reconciliation adds $8.6 million of transaction costs, up from $5.0 million a year earlier. Put those together and the two deals plus deal costs account for roughly $22 million of the $57.5 million operating loss.

The other swing is below the operating line. Interest income rose to $16.5 million from $5.0 million, and interest expense fell to $0.6 million from $7.4 million. Both moves come from the same source. Rocket Lab raised cash by selling stock and parked it in cash equivalents, and it retired most of its convertible notes by turning them into shares. Equity funding is now paying part of the income statement's bills directly.

The share count explains the rest of the EPS improvement. Weighted-average basic shares rose 22%, from 515.1 million to 629.7 million, so a 26% smaller net loss was spread across a much larger base. Per share, the loss improved by 38%. That is a narrower gain than the 62% revenue growth suggests.

Revenue Deep Dive: Space Systems Carries the Quarter​

Rocket Lab reports two segments: Launch Services (Electron, HASTE and, eventually, Neutron) and Space Systems (spacecraft, satellite components and now, through Mynaric, laser communications terminals).

Space Systems ($189.5M, +94%) is the whole growth story. The 10-Q attributes the $91.6 million increase to "spacecraft manufacturing growth and acquisitions." Mynaric and Motiv together contributed $14.6 million, so excluding the two Q2 deals, total revenue still grew about 52%. That figure still includes GEOST, the electro-optical payload maker acquired in August 2025, which was not in the Q2 2025 base. Space Systems now accounts for 81% of revenue. Rocket Lab still presents itself as a launch company, but its income statement belongs to a satellite manufacturer.

Launch Services ($44.6M, −4%) fell even though Rocket Lab flew more. The 10-Q counts six Electron launches in Q2 2026, against five a year earlier. Two of the six were HASTE suborbital missions, whose revenue is recognized over time and was partly booked in earlier quarters. Revenue per launch rose to $9.1 million from $7.9 million, and cost per launch fell to $4.4 million from $5.0 million. The 10-Q credits the per-launch gain to "changes in customer mix and mission complexity," not to price increases. Launch gross margin was the best in the company at 42.9%. Over the first half, launch revenue rose 32% on 12 Electron missions versus 10.

The demand language. The release is emphatic but specific. Founder and CEO Peter Beck says revenue was "driven by surging demand across all areas of our business". That is a robust demand signal, and the backlog supports it (see below). The 10-Q also uses supply-constraint language, but about Rocket Lab's own suppliers rather than its customers. Motiv, it says, brings "in-house costly and supply-constrained satellite components like solar array drive assemblies," and Mynaric "addresses a critical supply chain constraint for satellite constellation operators." Rocket Lab is buying its bottlenecks. On market expansion, the 10-Q says the Mynaric deal "establishes the Company's first European footprint," and the release notes a new Rocket Lab Germany GmbH. Nowhere does the release say demand exceeds supply, and nowhere does it claim rising prices.

Neutron is a product ramp that has not started yet. The release says "Production of the Stage 1 tank is currently aligned with the target delivery of Neutron to the launch pad in Q4 2026." That is a schedule statement, not a claim that the ramp is beating expectations. Neutron has no revenue line yet. Its cost sits inside the $82.4 million of R&D.

Backlog: $2.36 billion, of which 45% converts within a year​

Backlog is a disclosure, not an account, so it is not in the ledger. Its footprint is, though. Contract liabilities — customer advances and deposits, which the ledger books as Liabilities:Current:DeferredRevenue — rose from $195.4 million at year-end to $351.2 million on June 30. The 10-Q breaks that increase down. In Q2 alone, $75.8 million came in through acquisitions (almost all Mynaric's), $75.3 million came from new customer advances or billings, and $41.3 million was recognized as revenue. About 45% of the backlog, roughly $1.06 billion, is due to convert within twelve months. That is more than the last four quarters of revenue combined. The backlog also carries caveats. The release's post-quarter contract figures include options, and the 10-Q discloses that MDA Corporation may be entitled to liquidated damages for late spacecraft-bus deliveries under a 2022 contract.

The Margin Story​

The operating-margin improvement from −41% to −25% is mostly operating leverage in R&D. R&D grew 25% while revenue grew 62%, so it fell from 45.8% of revenue to 35.2%. SG&A grew faster, 50%, because it carries the $8.6 million of transaction costs and $3.3 million of intangible and favorable-lease amortization. Gross margin gained four points. Launch margin rose to 42.9% from 30.5% on lower cost per launch. Space Systems margin rose to 34.6% from 32.9%, even after amortization of purchased intangibles and favorable leases in cost of revenues rose to $7.2 million from $1.8 million.

Guidance points the other way. For Q3 2026 the release guides revenue to $250–265 million — another record — but GAAP gross margin to only 29–31%, and an adjusted EBITDA loss of $17–23 million. Q2's adjusted EBITDA loss was $8.8 million. The release does not say why margins are expected to fall. The amortization schedule in the 10-Q is part of the answer: $39.7 million of intangible amortization is due over the next twelve months, against $29.7 million estimated at year-end. That rise is the price of buying intangible assets.

On pricing, the numbers support a narrower claim than the demand language. Revenue per launch rose 15%, but the filing credits mix and complexity, not price. A rise in average selling price with no pricing language behind it is a mix effect until management says otherwise.

The One Big Question: How Much of the Growth Arrived as Equity?​

This is the question the balance sheet answers and the income statement cannot. The ledger's equity account is Equity:CommonStockAndAPIC: preferred and common stock at par plus additional paid-in capital. Here is how it moved in the first half of 2026, from the 10-Q's statement of changes in stockholders' equity:

And on the asset side, the acquisitions show up as goodwill and intangibles:

Put the two tables side by side and the answer comes out. Since the end of 2024, goodwill plus intangibles has risen from $129.7 million to $619.5 million, an increase of $490 million. Paid-in capital has risen from $1.20 billion to $4.61 billion, an increase of $3.41 billion. Only about $298 million of that new equity was stock handed to sellers: $137.7 million for GEOST and $160.8 million for Mynaric. About $337 million came from converting the 2029 convertible notes, which is why long-term debt fell from $389 million at the end of 2024 to under $15 million. The large majority, about $2.63 billion net, was cash raised by selling stock through ATM programs: roughly $1.12 billion in 2025 and $1.51 billion in the first half of 2026.

So "growth bought with equity" is true, but it happened mostly through cash. Most of what the stock sales raised has not yet been spent on anything. It sits in the $2.13 billion cash balance, up from $829 million at year-end. That makes goodwill and intangibles a smaller share of total assets (14.8%) than at year-end 2025 (18.5%), even though they are larger in dollars. The dilution is already here: outstanding shares grew 19% since December 2024, to 598.2 million. The assets the new shares are meant to fund are still mostly cash.

That cash has a destination. On June 28 Rocket Lab agreed to acquire Iridium Communications. Each Iridium share is to receive $27.00 in cash plus Rocket Lab stock at an exchange ratio of 0.4000 if Rocket Lab's share price is at or below $67.50, and a floating ratio above that. The deal is backed by a committed $3.6 billion bridge loan. None of it is in the June 30 ledger: the transaction had not closed, and the S-4 registering the shares was filed in August. When it closes, this ledger will show another step change in goodwill and share count, and for the first time in years, meaningful debt.

The SpaceX comparison. Rocket Lab's sector peer in this fleet is the SpaceX ledger, whose Q2 2026 period we modeled from its first 10-Q. Both companies raised equity on a scale their income statements could not justify on their own, but they spent it differently:

SpaceX's equity is going into data centers and Starship. Rocket Lab's is going into companies. Rocket Lab's goodwill and intangibles are twice as large a share of its assets as SpaceX's, and the Iridium deal will widen that gap. The two ledgers show two different uses of new equity: one company builds its own capacity, the other acquires it.

Tracking a $4 Billion Space Company in Plain Text​

A double-entry ledger is a good lens for a company like this because it will not let an acquisition hide. Every dollar of goodwill needs an equal dollar of consideration somewhere, whether cash out, stock in or an earnout liability. We model Rocket Lab the same way we model every company in the fleet (how we model every company). The balance sheet is a set of pad + balance assertions at each period end, and the income statement is a single transaction that must sum to zero. Income postings are negative (credits), expense postings are positive (debits), and Equity:Adjustments absorbs the net loss. Rocket Lab reports in thousands, so the ledger keeps three decimals of its MUSD unit.

Here is the Q2 2026 income statement exactly as pushed to the ledger:

; FY2026Q2 Income Statement — three months ended June 30, 2026 — Q2 only
; Net loss as filed: (49,258) USD thousands
; Check: -234.066 + 149.490 + 82.429 + 59.661 − 13.583 + 5.327 − 49.258 = 0 ✓
 
2026-06-30 * "Rocket Lab Corporation" "FY2026Q2 Income Statement"
  Income:Revenue                               -234.066 MUSD  ; total revenues; Space Systems 189,480 + Launch Services 44,586 (10-Q Note 3)
  Expenses:CostOfRevenue                        149.490 MUSD  ; total cost of revenues
  Expenses:ResearchAndDevelopment                82.429 MUSD  ; research and development, net
  Expenses:SellingGeneralAdministrative          59.661 MUSD  ; selling, general and administrative
  Income:OtherNet                               -13.583 MUSD  ; total other income (expense), net
  Expenses:IncomeTax                              5.327 MUSD  ; provision for income taxes
  Equity:Adjustments                            -49.258 MUSD  ; net loss offset (RE set by balance assertion)

Income:OtherNet is a credit here because Rocket Lab's other income was net positive this quarter, mostly interest earned on the stock-sale cash. In FY2021 and FY2023 the same line was a net expense and sits on Expenses:OtherNet instead. The four balance assertions that tell this post's story are these:

2026-06-30 balance Assets:NonCurrent:Goodwill                     299.072 MUSD  ; Goodwill
2026-06-30 balance Assets:NonCurrent:IntangibleAssets             320.415 MUSD  ; Intangible assets, net
2026-06-30 balance Liabilities:Current:DeferredRevenue           -351.193 MUSD  ; Contract liabilities (customer advances and deposits)
2026-06-30 balance Equity:CommonStockAndAPIC                    -4606.918 MUSD  ; preferred stock 4 + common stock 60 + APIC 4,606,854

The number to watch is Equity:CommonStockAndAPIC. It was −1,002.151 MUSD at the end of 2021 and −1,198.959 at the end of 2024. It is −4,606.918 now. Every dollar of the $3.4 billion jump since 2024 came from equity: shares sold for cash, handed to a seller or converted from a note, plus stock compensation granted to employees.

The Multi-Year Arc​

The five-year arc has two phases. From 2021 to 2024, Rocket Lab grew revenue sevenfold, from $62 million to $436 million. Gross margin climbed from negative to 27%, and paid-in capital barely moved after the 2021 SPAC merger lifted it to $1.0 billion. The 2021–2022 deals (ASI, PSC, SolAero) left goodwill and intangibles at about $130–150 million, and that figure drifted down through amortization for two years.

The second phase began in 2025. Revenue kept compounding, rising 38% to $602 million, and the gross margin reached 34%. But the balance sheet changed character. Paid-in capital more than doubled in 2025 and rose another 68% in the first half of 2026. Goodwill and intangibles more than tripled with GEOST and rose again with Mynaric and Motiv. The net loss has stayed in a narrow band of $180–200 million a year since 2023 even as revenue grew 2.5×. That is operating leverage, but not yet profit. Q2's −$49.3 million annualizes to about −$200 million. The losses stayed about the same size while the equity base funding them nearly quadrupled.

The Verdict: Bull vs. Bear​

Bull Case

• Backlog of $2.36 billion (+137%) covers about ten quarters of current revenue, and ~$1.06 billion of it converts within twelve months, more than FY2025's entire $602 million revenue.
• Customer cash arrives before revenue: contract liabilities rose to $351 million, and $75 million of new advances came in Q2 alone.
• Operating leverage is real: R&D fell from 45.8% to 35.2% of revenue in a year, and the operating loss shrank even as two loss-making acquisitions were absorbed.
• The balance sheet can fund Neutron and the Iridium cash component: $2.13 billion of cash plus $258 million of marketable securities, against less than $15 million of long-term debt.
• Vertical integration is making Rocket Lab its own supplier: Mynaric (laser terminals) and Motiv (solar array drives, mechanisms) are components the 10-Q itself calls supply-constrained.

Bear Case

• EPS improved partly because the share count rose 22%. Per-share value depends on the acquired businesses earning a return, and Mynaric lost $13.2 million on $13.2 million of revenue in its first quarter.
• Q3 guidance calls for GAAP gross margin of 29–31%, down from 36.1%, and a larger adjusted EBITDA loss. The "surging demand" language has not yet shown up in margins.
• Launch revenue fell 4% in Q2 despite one more launch. Neutron, the vehicle meant to change launch economics, has no revenue and a Q4 2026 pad-delivery target that the release describes only as "aligned."
• Iridium will add a $3.6 billion bridge-loan commitment and more shares to a company that has not reported an annual profit in any year this ledger covers. The ledger's near-zero debt line is about to end.
• Goodwill and intangibles have grown from $130 million to $620 million in 18 months, and amortization is rising: $39.7 million is due over the next twelve months, a cost that runs through GAAP margins every quarter.

Our Take

Rocket Lab's Q2 is a good quarter for the business and a warning for anyone reading only the income statement. Most of the revenue growth came from outside the two Q2 deals, and the backlog is real. But what the balance sheet says matters more than the records the release highlights. Since the end of 2024, shareholders have supplied $3.4 billion of new paid-in capital, and the company has converted $490 million of it into goodwill and intangibles. Iridium is about to convert much more. The ledger will show whether that capital earns a return, because under double-entry, every acquisition has to reconcile. The test for FY2026 is simple and falsifiable: does gross margin hold above 30% once Iridium's amortization arrives, and does the net loss per share keep shrinking while the share count keeps rising? We think the backlog makes the first plausible. We are not yet convinced of the second. Rocket Lab is well funded, it is growing fast, and it is paying for that growth with new shares.